# 68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.

> **NCT06151119** · — · RECRUITING · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 90 (estimated)

## Conditions studied

- Primary Myelofibrosis

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga FAPI PET/CT

## Key facts

- **NCT ID:** NCT06151119
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-22
- **Primary completion:** 2026-10-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06151119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06151119, "68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06151119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*